Buy
Sell
Share Name Share Symbol Market Type
Abionyx Pharma EU:ABNX Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.006 0.32% 1.89 1.84 1.90 1.90 1.822 1.872 137,129 16:40:00

ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

03/08/2022 5:00pm

Business Wire


Abionyx Pharma (EU:ABNX)
Historical Stock Chart


From Jul 2022 to Jan 2023

Click Here for more Abionyx Pharma Charts.

 Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority)

Regulatory News:

ABIONYX Pharma (Paris:ABNX):

Date

Number of shares outstanding

Total voting rights

Total gross (1)

Total net (2)

July 31, 2022

27 914 274

27 914 274

27 676 052

(1) The total number of gross (or “theoretical”) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.

(2) The total number of net (or “exercisable at a Shareholders’ Meeting”) voting rights is calculated without taking into account shares for which voting rights have been suspended. It is released in order to ensure that the public is properly informed, in accordance with the recommendation made by the AMF on 17 July 2007.

About ABIONYX Pharma

ABIONYX Pharma is a new generation biotech company that aims to contribute to health through innovative therapies in indications where there is no effective or existing treatment, even the rarest ones. Thanks to its partners in research, medicine, biopharmaceuticals and shareholding, the company innovates on a daily basis to propose drugs for the treatment of renal and ophthalmological diseases, or new HDL vectors used for targeted drug delivery.

NewCap Investor relations Louis-Victor Delouvrier Nicolas Fossiez abionyx@newcap.eu +33 (0)1 44 71 98 53

NewCap Media relations Arthur Rouillé abionyx@newcap.eu +33 (0)1 44 71 00 15

1 Year Abionyx Pharma Chart

1 Year Abionyx Pharma Chart

1 Month Abionyx Pharma Chart

1 Month Abionyx Pharma Chart
Your Recent History
EU
ABNX
Abionyx Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20230129 12:43:09